These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 37527538

  • 1. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
    Li Z, Dai R, Chen M, Huang L, Zhu K, Li M, Zhu W, Li Y, Xie N, Li J, Wang L, Lan F, Cao CM.
    Cardiovasc Res; 2023 Nov 15; 119(14):2421-2440. PubMed ID: 37527538
    [Abstract] [Full Text] [Related]

  • 2. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A, Chen BD, Liu F, Chen XC, Gai MT, Li XM, Ma YT, Du XJ, Yang YN, Gao XM.
    Clin Sci (Lond); 2019 Mar 15; 133(5):665-680. PubMed ID: 30804219
    [Abstract] [Full Text] [Related]

  • 3. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
    Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM, Xiao RP.
    Cardiovasc Res; 2011 Jul 01; 91(1):108-15. PubMed ID: 21285295
    [Abstract] [Full Text] [Related]

  • 4. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1.
    Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X, Fan GC.
    Cardiovasc Res; 2012 May 01; 94(2):379-90. PubMed ID: 22354898
    [Abstract] [Full Text] [Related]

  • 5. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H2O2-Activated Protein Kinase C-δ Signaling.
    Shan D, Guo S, Wu HK, Lv F, Jin L, Zhang M, Xie P, Wang Y, Song Y, Wu F, Lan F, Hu X, Cao CM, Zhang Y, Xiao RP.
    Circulation; 2020 Sep 15; 142(11):1077-1091. PubMed ID: 32677469
    [Abstract] [Full Text] [Related]

  • 6. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.
    Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, Hippe HJ, Linkermann A, Wolf MJ, Rose-John S, Lüllmann-Rauch R, Adam D, Flögel U, Heikenwalder M, Luedde T, Frey N.
    Cardiovasc Res; 2014 Jul 15; 103(2):206-16. PubMed ID: 24920296
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb 15; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 8. MG53 constitutes a primary determinant of cardiac ischemic preconditioning.
    Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, Lv F, Zhang Y, Song R, Hwang M, Jin L, Guo J, Peng W, Li G, Nishi M, Takeshima H, Ma J, Xiao RP.
    Circulation; 2010 Jun 15; 121(23):2565-74. PubMed ID: 20516375
    [Abstract] [Full Text] [Related]

  • 9. Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model.
    Luo Z, Hu X, Wu C, Chan J, Liu Z, Guo C, Zhu R, Zhang L, Zhang Y, Jin S, He S.
    Br J Anaesth; 2023 Jan 15; 130(1):29-38. PubMed ID: 36347723
    [Abstract] [Full Text] [Related]

  • 10. The significance of the washout period in preconditioning.
    Salie R, Lochner A, Loubser DJ.
    Cardiovasc Ther; 2017 Jun 15; 35(3):. PubMed ID: 28118517
    [Abstract] [Full Text] [Related]

  • 11. Stat5-dependent cardioprotection in late remote ischaemia preconditioning.
    Chen H, Jing XY, Shen YJ, Wang TL, Ou C, Lu SF, Cai Y, Li Q, Chen X, Ding YJ, Yu XC, Zhu BM.
    Cardiovasc Res; 2018 Apr 01; 114(5):679-689. PubMed ID: 29365089
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.
    Maciel L, de Oliveira DF, Verissimo da Costa GC, Bisch PM, Nascimento JHM.
    Basic Res Cardiol; 2017 Sep 01; 112(5):52. PubMed ID: 28695353
    [Abstract] [Full Text] [Related]

  • 13. Metformin mediates cardioprotection against aging-induced ischemic necroptosis.
    Li C, Mu N, Gu C, Liu M, Yang Z, Yin Y, Chen M, Wang Y, Han Y, Yu L, Ma H.
    Aging Cell; 2020 Feb 01; 19(2):e13096. PubMed ID: 31944526
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning.
    Lankford AR, Yang JN, Rose'Meyer R, French BA, Matherne GP, Fredholm BB, Yang Z.
    Am J Physiol Heart Circ Physiol; 2006 Apr 01; 290(4):H1469-73. PubMed ID: 16299262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE, Javadov S, Escobales N.
    Clin Exp Pharmacol Physiol; 2017 Dec 01; 44(12):1201-1212. PubMed ID: 28707739
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.